• 提示：詳情請(qǐng)下載說(shuō)明書。

• 產(chǎn)品描述： Molibresib (I-BET762; GSK525762) is a BET bromodomain inhibitor with IC50 of 32.5-42.5 nM.

• 靶點(diǎn)： IC50: 32.5-42.5 nM (BET);EpigeneticReaderDomain

• 體內(nèi)研究：
  The antimyeloma activity of Molibresib (I-BET 762) is tested dosed orally in an in vivo systemic xenograft model generated by injecting OPM-2 cells into NOD-SCID mice. Daily oral doses of Molibresib up to 10 mg/kg and 30 mg/kg given every other day are well tolerated with no clear impact on body weight compared with vehicle control. The plasma hLC concentration is significantly reduced in mice treated with Molibresib

• 參考文獻(xiàn)：
  1. Nicodeme E, et al. Suppression of inflammation by a synthetic histone mimic. Nature. 2010 Dec 23;468(7327):1119-23. 2. Asangani IA, et al. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. Nature. 2014 Jun 12;510(7504):278-82. 3. Chaidos A, et al. Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762. Blood. 2014 Jan 30;123(5):697-705.

• 溶解性： DMSO  :  200  mg/mL  (471.81  mM;  Need  ultrasonic)    1M  HCl  :  100  mg/mL  (235.90  mM;  ultrasonic  and  adjust  pH  to  1  with  HCl)

• 保存條件： 2-8℃

• 配置溶液濃度參考：
  

  	1mg	5mg	10mg
  1 mM	2.359 ml	11.795 ml	23.59 ml
  5 mM	0.472 ml	2.359 ml	4.718 ml
  10 mM	0.236 ml	1.18 ml	2.359 ml
  50 mM	0.047 ml	0.236 ml	0.472 ml

• 注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

輸入產(chǎn)品批號(hào)：

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系，公式為：

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

• pg ng μg mg g kg =
  fM pM nM μM mM M *
  nL μL mL L *